E-Cigarette Use Poses Severe Respiratory Threat To Young People Within 30 Days: Study
New Study: Morphine Use Among Cancer Patients Linked To Bone Loss And Pain, Is Medical Marijuana An Option?
Bipartisan Letter Calls For Including Active Service Members In Psychedelic-Assisted Therapy Research
NIDA Director Dr. Nora Volkow Calls For 'Urgent' Research Into Risks Of Regular Cannabis Use, Citing Effects On Brain Development
National Institutes Of Health Recent News
House Passes Revised Cannabis Research Bill, Senate Expected To 'Move Quickly'
Government-Funded Smoking Cessation Trial Uses Mydecine's New Psilocybin-Derived MYCO-001, Recently FDA-Approved
Cannabis In Cancer Treatment: Feds To Fund New Research In These Areas Of Interest
Historic: Federal Agency Awards Grant For Psychedelics Research, First Time In 50 years
Emergent BioSolutions' COVID-19 Plasma Candidate To Be Tested As Outpatient Treatment
Trevena's TRV027 To Be Tested In NIH-Funded COVID-19 Trial
NIH Starts Study On Allergic Reactions Risk To Pfizer/BioNTech, Moderna COVID-19 Vaccines
No Conclusive Evidence On Convalescent Plasma Use Against COVID-19, NIH Says After FDA Emergency Use Approval
Gilead's Remdesivir-Like Compound To Be Studied By NIH For Efficacy Against COVID-19
Pain Therapeutics Granted $3.5M For Alzheimer's Study, CEO Comments On Micro-Cap Volatility
What Would A $5.8 Billion NIH Cut Look Like? Devastation.
U.S. Researchers Begin Clinical Trial Of Zika Vaccine, But Funding To Run Out By August's End
Medivation Drops 12% After Congress Asks To Examine Xtandi Drug Price
Market Wrap For January 13: Markets Showing Weakness Ahead Of Major Earning Releases